Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Rev Esp Quimioter ; 34(3): 200-206, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33724755

RESUMEN

OBJECTIVE: To describe the avoided costs and to analyze the effectiveness of intravenous antibiotic treatment in continuous perfusion in patients at Hospital at Home Units (HHU) administered using elastomeric infusion pumps (EIP) prepared in a Hospital Pharmacy Service (HPS). METHODS: Retrospective observational study of the number and type of EIP prepared in the HPS and of the treated patients. Study period: January 2017-December2018. Analyzed data: demographic data of patients, location of infection, responsible microorganism, medication and type of EIP, dose and duration of treatment and its effectiveness in terms of cure or non-cure or patient's death. Economic valuation considering: costs of EIP, nursing time needed for preparation and cost of HHU care. RESULTS: A total of 1,688 EIP to treat 102 patients resulted in 106 episodes of outpatient treatment of parenteral antibiotic therapy (OPAT) for 1,409 days, thereby avoiding 1,409 days of hospital admission. A total of 59.8% of the patients were men and the mean age was 70.5 ± 17 years. A 31.1% and 68.9% of the cases were empirical and pathogen-directed treatments, respectively. The most used antimicrobials were piperacillin/tazobactam (42.7%), ceftazidime (24.5%), meropenem (19.8%), ceftolozane/tazobactam (2.8%), and cloxacillin (1.9%). Mean duration of treatment was 13.29 ± 8.60 days. Location of infection: respiratory (42.5%), urinary (17.9%), skin and soft tissue (12.3%), bacteraemia (11.3%), osteomyelitis (7.5%), abdominal (3.8%) and 4.7% in other locations. The cure rate was 84%. Total avoided cost: 580,788.28€ in the 24 months studied. CONCLUSIONS: This program represents very important economic savings for the health system, and the effectiveness of the antibiotic treatment has not been compromised.


Asunto(s)
Antibacterianos , Ceftazidima , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Hospitales , Humanos , Bombas de Infusión , Masculino , Meropenem , Persona de Mediana Edad
3.
Aten Primaria ; 20(4): 195-7, 1997 Sep 15.
Artículo en Español | MEDLINE | ID: mdl-9410143

RESUMEN

OBJECTIVE: To evaluate the use of "Hospital Care at home for trauma patients" from the perspective of decreasing the average hospital stay and termining the home care load engendered. DESIGN: Longitudinal descriptive study. SETTING: The Hospital Care at home unit of the Juan Canalejo hospital in La Coruña. PATIENTS: Patients belonging to the city of La Coruña or adjacent towns, who were operated on during the first six months of the programme for a trauma pathology (hip fracture, coxarthrosis, gonarthrosis). MEASUREMENTS AND MAIN RESULTS: The clinical records were reviewed. The following data were considered: number of patients, age, length of hospital stay, length of home follow-up, number of home medical and nursing visits required. CONCLUSIONS: This type of patient spends less time on average in hospital.


Asunto(s)
Fracturas de Cadera/terapia , Servicios de Atención a Domicilio Provisto por Hospital , Tiempo de Internación , Osteoartritis/terapia , Anciano , Estudios de Evaluación como Asunto , Estudios de Seguimiento , Fracturas de Cadera/cirugía , Humanos , Articulación de la Rodilla , Estudios Longitudinales , Persona de Mediana Edad , Osteoartritis/cirugía , Osteoartritis de la Cadera/cirugía , Osteoartritis de la Cadera/terapia , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA